Multi-Drug Resistant Bacteria Carriage After Travel

Beta Lactam Resistant Bacterial Infection (Disorder) Clinical Trial

Official title:

Multi-Drug Resistant Bacteria Carriage After Travel: Comparison Between Patients Who Have Been Hospitalized in a Foreign Country, or Not During the Previous Year

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03477760
• Other study ID #: MRB after travel
• Status: Completed
• First received: March 18, 2018
• Last updated: March 18, 2018
• Start date: November 2016
• Est. completion date: December 2016

Study information

• Verified date: March 2018
• Source: Hopital Lariboisière
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

During one month, from 1st to 30th November 2016, all patients admitted in one of the medical Dpt of our Hospital (Internal Medicine Dpt, Endocrinology, ICU) will be screened for multi-drug resistant bacteria carriage (after written consent). They will answer to a questionnaire about previous travel in a foreign country during the previous year, hospitalization or not during this travel.

Description:

During one month, from 1st to 30th November 2016, all patients admitted in one of the medical Dpt of our Hospital (Internal Medicine Dpt, Endocrinology, ICU) will be screened for multi-drug resistant bacteria carriage (after written consent), regardless a travel in a foreign country during the past year, or not. They will answer to a questionnaire about previous travel in a foreign country during the previous year, hospitalization or not during this travel. The aim of the study will be to compare the rate of carriage of multi-drug resistant bacteria among previous travelers, or not.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 300
• Est. completion date: December 2016
• Est. primary completion date: December 2016
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• All patients admitted in one of the medical Dpt of our Hospital who have travelled in a foreign country during the previous year

Exclusion Criteria:

• patients who were unable to give written consent

Related Conditions & MeSH terms

• Bacterial Infections
• Beta Lactam Resistant Bacterial Infection (Disorder)

Intervention

Biological:
• rectal swab for Multi-Drug resistant bacteria
A rectal swab will be performed at admission of patients to look for intestinal carriage of Multi-Drug resistant bacteria

Locations

Country	Name	City	State
France	URT, Hopital Lariboisiere	Paris	Ile-de-France

Sponsors (1)

Lead Sponsor	Collaborator
Hopital Lariboisière

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Multi-Drug Resistant bacteria carriage rate	Multi-Drug Resistant bacteria carriage assessed by rectal swab	At admission in our Hospital